In the field of oncology the use of targeted medications is becoming more commonplace to address various conditions. Research is being done in other areas of medicine, including psychiatry to see if there is more that can be done to address this patient population as well.
Talking about mental health conditions may be easier than it was a few years ago but the stigma still exists in many parts of the population. The National Alliance on Mental Illness is working to overcome that issue on a variety of fronts.
Allergan has made a name for itself in the treatment of many neurological and mental health conditions and continues to grow its portfolio. One of its newest offerings is cariprazine which they hope will be a powerful tool in the antipsychotic area.
Previous research has red-flagged migraines as being associated with silent brain infarcts and white matter hyperintensities (WMH). However, a team of doctors in Denmark found zero evidence to back that up.
As the population gets older more questions are being asked about what can be done to prevent dementia and whether there are certain activities which are better suited to achieve this goal if it is possible.